Annual Net Margin
-137.90%
-61.20%-79.79%
December 31, 2024
Summary
- As of February 26, 2025, TVTX annual net profit margin is -137.90%, with the most recent change of -61.20% (-79.79%) on December 31, 2024.
- During the last 3 years, TVTX annual net margin has fallen by -1.30% (-0.95%).
- TVTX annual net margin is now -284.55% below its all-time high of -35.86%, reached on December 31, 2016.
Performance
TVTX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-80.58%
+6.56%+7.53%
December 1, 2024
Summary
- As of February 26, 2025, TVTX quarterly net profit margin is -80.58%, with the most recent change of +6.56% (+7.53%) on December 1, 2024.
- Over the past year, TVTX quarterly net margin has increased by +119.54% (+59.73%).
- TVTX quarterly net margin is now -308.38% below its all-time high of 38.67%, reached on March 31, 2016.
Performance
TVTX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
TVTX Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -79.8% | +59.7% |
| 3 y3 years | -0.9% | +59.7% |
| 5 y5 years | -65.1% | +59.7% |
TVTX Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.8% | +45.8% | at high | +75.5% |
| 5 y | 5-year | -79.8% | +45.8% | -4868.1% | +75.5% |
| alltime | all time | -284.6% | +64.9% | -308.4% | +100.0% |
Travere Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -137.90%(+79.8%) | - |
| Dec 2024 | - | -80.58%(-7.5%) |
| Sep 2024 | - | -87.14%(-33.0%) |
| Jun 2024 | - | -130.11%(-60.4%) |
| Mar 2024 | - | -328.86%(+64.3%) |
| Dec 2023 | -76.70%(-69.9%) | -200.12%(-24.8%) |
| Jun 2023 | - | -265.96%(-4.8%) |
| Mar 2023 | - | -279.50%(+24.6%) |
| Dec 2022 | -254.41%(+86.2%) | -224.35%(-9.6%) |
| Sep 2022 | - | -248.11%(+100.5%) |
| Jun 2022 | - | -123.75%(-21.0%) |
| Mar 2022 | - | -156.68%(+199.9%) |
| Dec 2021 | -136.60%(+59.9%) | - |
| Sep 2021 | - | -52.24%(-26.9%) |
| Jun 2021 | - | -71.43%(-37.1%) |
| Mar 2021 | - | -113.63%(-52.4%) |
| Dec 2020 | -85.43%(+2.3%) | -238.55%(+441.1%) |
| Sep 2020 | - | -44.09%(-18.1%) |
| Jun 2020 | - | -53.83%(-3285.2%) |
| Mar 2020 | - | 1.69%(-102.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -83.51%(+33.6%) | -64.81%(-21.2%) |
| Sep 2019 | - | -82.23%(-5.0%) |
| Jun 2019 | - | -86.57%(-16.4%) |
| Mar 2019 | - | -103.56%(+508.1%) |
| Dec 2018 | -62.51%(+62.2%) | -17.03%(-87.3%) |
| Sep 2018 | - | -133.93%(+147.9%) |
| Jun 2018 | - | -54.02%(+13.0%) |
| Mar 2018 | - | -47.82%(+14.5%) |
| Dec 2017 | -38.55%(+7.5%) | -41.77%(-5.3%) |
| Sep 2017 | - | -44.11%(+29.4%) |
| Jun 2017 | - | -34.10%(+3.4%) |
| Mar 2017 | - | -32.99%(+43.1%) |
| Dec 2016 | -35.86%(-90.9%) | -23.05%(-78.9%) |
| Sep 2016 | - | -109.33%(+171.7%) |
| Jun 2016 | - | -40.24%(-204.1%) |
| Mar 2016 | - | 38.67%(-576.8%) |
| Dec 2015 | - | -8.11%(-92.4%) |
| Jun 2015 | - | -106.06%(-48.5%) |
| Dec 2014 | -393.36% | -206.08%(-4.3%) |
| Sep 2014 | - | -215.36%(-99.9%) |
| Mar 2014 | - | -271.45 K% |
FAQ
- What is Travere Therapeutics annual net profit margin?
- What is the all time high annual net margin for Travere Therapeutics?
- What is Travere Therapeutics annual net margin year-on-year change?
- What is Travere Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Travere Therapeutics?
- What is Travere Therapeutics quarterly net margin year-on-year change?
What is Travere Therapeutics annual net profit margin?
The current annual net margin of TVTX is -137.90%
What is the all time high annual net margin for Travere Therapeutics?
Travere Therapeutics all-time high annual net profit margin is -35.86%
What is Travere Therapeutics annual net margin year-on-year change?
Over the past year, TVTX annual net profit margin has changed by -61.20% (-79.79%)
What is Travere Therapeutics quarterly net profit margin?
The current quarterly net margin of TVTX is -80.58%
What is the all time high quarterly net margin for Travere Therapeutics?
Travere Therapeutics all-time high quarterly net profit margin is 38.67%
What is Travere Therapeutics quarterly net margin year-on-year change?
Over the past year, TVTX quarterly net profit margin has changed by +119.54% (+59.73%)